Probiotic Lactobacillus acidophilus ameliorates liver damage in DSS-induced ulcerative colitis mice by facilitating the transport of lithocholic acid in the gut-liver axis

Liver injury is a common extraintestinal manifestation of ulcerative colitis (UC). This study aimed to evaluate the protective effects and underlying mechanisms of Lactobacillus acidophilus (LA) on dextran sulfate sodium (DSS)-induced UC-associated liver damage (UCLD) in mice. LA administration significantly ameliorated weight loss, colonic shortening, and histopathological damage in UCLD mice, while concurrently attenuating the liver appearance, hepatocyte swelling and elevated ALT/AST levels. Depletion of gut microbiota by antibiotic cocktail treatment abrogated UCLD progression and abolished LA's protective effects, indicating microbiota dependency. Metabolomic analysis revealed that LA enhanced the gut-liver axis transport of lithocholic acid (LCA), a secondary bile acid produced by gut microbiota. Further experiments demonstrated that exogenous LCA improved hepatic histology, liver enzyme levels, and immune homeostasis in UCLD mice, with 60 mg/kg being the optimal dose. RNA-sequencing analysis revealed that 60 mg/kg LCA significantly modulated hepatic transcriptional profiles associated with P450 metabolism, chemical carcinogenesis and bile secretion. Notably, LCA restored the expression of key genes involved in bile acid hydrolysis and transport, highlighting its regulatory role in the gut-liver axis. Collectively, our findings demonstrate that LA alleviates UCLD by facilitating the microbiota-LCA transport axis, particularly through LCA-mediated regulation of hepatic immunity and gene expression. This provides a mechanistic rationale for using LA as a dietary supplement to prevent or treat UC-associated liver complications.

Authors

Institutions

Publication Details

Journal
Journal of Functional Foods
Published
2026-11-21
DOI
https://doi.org/10.1016/j.jff.2026.107588
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Probiotic Lactobacillus acidophilus ameliorates liver damage in DSS-induced ulcerative colitis mice by facilitating the transport of lithocholic acid in the gut-liver axis

Chaoying Pei, Kaiwei Cai, Ying Chen, Yanlong Chen et al.
Journal of Functional Foods
Inflammatory Bowel Disease
article

Probiotic Lactobacillus acidophilus ameliorates liver damage in DSS-induced ulcerative colitis mice by facilitating the transport of lithocholic acid in the gut-liver axis

Chaoying Pei, Kaiwei Cai, Ying Chen, Yanlong Chen, Na Yang, Qiongfeng Liao, Xingyuan Zhang, Song Deng, Zhiyong Xie, Pei Li
article en

Abstract

Liver injury is a common extraintestinal manifestation of ulcerative colitis (UC). This study aimed to evaluate the protective effects and underlying mechanisms of Lactobacillus acidophilus (LA) on dextran sulfate sodium (DSS)-induced UC-associated liver damage (UCLD) in mice. LA administration significantly ameliorated weight loss, colonic shortening, and histopathological damage in UCLD mice, while concurrently attenuating the liver appearance, hepatocyte swelling and elevated ALT/AST levels. Depletion of gut microbiota by antibiotic cocktail treatment abrogated UCLD progression and abolished LA's protective effects, indicating microbiota dependency. Metabolomic analysis revealed that LA enhanced the gut-liver axis transport of lithocholic acid (LCA), a secondary bile acid produced by gut microbiota. Further experiments demonstrated that exogenous LCA improved hepatic histology, liver enzyme levels, and immune homeostasis in UCLD mice, with 60 mg/kg being the optimal dose. RNA-sequencing analysis revealed that 60 mg/kg LCA significantly modulated hepatic transcriptional profiles associated with P450 metabolism, chemical carcinogenesis and bile secretion. Notably, LCA restored the expression of key genes involved in bile acid hydrolysis and transport, highlighting its regulatory role in the gut-liver axis. Collectively, our findings demonstrate that LA alleviates UCLD by facilitating the microbiota-LCA transport axis, particularly through LCA-mediated regulation of hepatic immunity and gene expression. This provides a mechanistic rationale for using LA as a dietary supplement to prevent or treat UC-associated liver complications.

Journal of Functional FoodsVol. 147
Guangzhou University of Chinese Medicine (CN), Sun Yat-sen University (CN), Guangdong Pharmaceutical University (CN), State Administration of Traditional Chinese Medicine of the People's Republic of China (CN), Shantou University (CN), Yue Bei People's Hospital (CN)
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon